Isoflurane Piramal Critical Care

Isoflurane, the active ingredient in Isoflurane Piramal Critical Care, is an inhalational anesthetic presented as a volatile liquid for inhalation use. It is employed to induce and maintain a state of general anesthesia in surgical and critical‑care settings. GNH USA supplies Isoflurane Piramal Critical Care as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Isoflurane is used in the anesthetic pathway to provide rapid and controllable loss of consciousness for surgical procedures. - Induction of general anesthesia: produces quick unconsciousness to begin operative interventions. - Maintenance of general anesthesia: sustains unconsciousness and analgesia throughout the procedure. - Controlled ventilation support: facilitates mechanical ventilation in critical‑care patients requiring anesthetic depth.

Isoflurane may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Cough or airway irritation during administration. - Nausea or vomiting during emergence. - Hypotension due to vasodilation. - Tachycardia or transient arrhythmias. - Dry mouth or sore throat. - Lightheadedness on awakening.

Serious or Rare Side Effects: - Malignant hyperthermia in susceptible individuals. - Severe hepatic dysfunction or jaundice. - Profound hypotension unresponsive to fluids. - Cardiac arrhythmias requiring intervention. - Respiratory depression persisting after discontinuation. - Anaphylactoid reactions with bronchospasm.

Isoflurane administration requires careful monitoring and specific safety measures. - Patient monitoring: continuous cardiovascular and respiratory observation is essential. - Airway management: secure airway before initiating inhalation. - Sensitivity: avoid in patients with known hypersensitivity to volatile anesthetics. - Organ function: use cautiously in hepatic or renal impairment. - Pregnancy: limited data; weigh benefits against potential risks. - Store at ambient temperature: keep container sealed, protect from light and heat, store below 25°C.

Isoflurane can interact with other agents, altering its safety profile.

Major Interactions (Avoid): - Halothane: additive hepatotoxic potential. - Sodium channel blockers (e.g., lidocaine): increased central nervous system depression. - Monoamine oxidase inhibitors: unpredictable cardiovascular effects.

Moderate Interactions (Monitor Closely): - Opioids: enhanced respiratory depression. - Benzodiazepines: additive sedative effect. - Beta‑blockers: may potentiate hypotensive response.